You have free access to this content

Hepatology

Cover image for Vol. 48 Issue 2

August 2008

Volume 48, Issue 2

Pages 353–695

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
    2. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
    2. You have free access to this content
      A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection (pages 374–384)

      Clovis Palmer, Taline Hampartzoumian, Andrew Lloyd and Amany Zekry

      Version of Record online: 21 APR 2008 | DOI: 10.1002/hep.22387

    3. You have free access to this content
      R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin (pages 385–397)

      Paul J. Pockros, David Nelson, Eliot Godofsky, Maribel Rodriguez-Torres, Gregory T. Everson, Michael W. Fried, Reem Ghalib, Stephen Harrison, Lisa Nyberg, Mitchell L. Shiffman, Isabel Najera, Anna Chan and George Hill

      Version of Record online: 20 JUN 2008 | DOI: 10.1002/hep.22357

    4. You have free access to this content
      Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C (pages 398–406)

      Stuart K. Roberts, Graham Cooksley, Gregory J. Dore, Richard Robson, David Shaw, Heather Berns, George Hill, Klaus Klumpp, Isabel Najera and Carla Washington

      Version of Record online: 18 MAR 2008 | DOI: 10.1002/hep.22321

    5. You have free access to this content
      Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C (pages 407–417)

      Stefan Zeuzem, Eric M. Yoshida, Yves Benhamou, Stephen Pianko, Vincent G. Bain, Daniel Shouval, Robert Flisiak, Vratislav Rehak, Mircea Grigorescu, Kelly Kaita, Patrick W. Cronin, Erik Pulkstenis, G. Mani Subramanian and John G. McHutchison

      Version of Record online: 9 MAY 2008 | DOI: 10.1002/hep.22403

    6. You have free access to this content
  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice (pages 432–441)

      Xiaomei Qin, Xuefen Xie, Yanbo Fan, Jianwei Tian, Youfei Guan, Xian Wang, Yi Zhu and Nanping Wang

      Version of Record online: 24 MAR 2008 | DOI: 10.1002/hep.22334

    2. You have free access to this content
      Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis (pages 442–448)

      Valerio Nobili, Francesco Vizzutti, Umberto Arena, Juan G. Abraldes, Fabio Marra, Andrea Pietrobattista, Rodolfo Fruhwirth, Matilde Marcellini and Massimo Pinzani

      Version of Record online: 18 APR 2008 | DOI: 10.1002/hep.22376

    3. You have free access to this content
      Visceral fat: A key mediator of steatohepatitis in metabolic liver disease (pages 449–457)

      David van der Poorten, Kerry-Lee Milner, Jason Hui, Alexander Hodge, Michael I. Trenell, James G. Kench, Roslyn London, Tony Peduto, Donald J. Chisholm and Jacob George

      Version of Record online: 11 APR 2008 | DOI: 10.1002/hep.22350

    4. You have free access to this content
      Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice (pages 458–473)

      Kengo Tomita, Yuichi Oike, Toshiaki Teratani, Takashi Taguchi, Masaaki Noguchi, Takahiro Suzuki, Akiko Mizutani, Hirokazu Yokoyama, Rie Irie, Hidetoshi Sumimoto, Atsushi Takayanagi, Kiichi Miyashita, Masaki Akao, Mitsuhisa Tabata, Gen Tamiya, Tamiko Ohkura and Toshifumi Hibi

      Version of Record online: 15 APR 2008 | DOI: 10.1002/hep.22365

    5. You have free access to this content
      Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis (pages 474–486)

      Kristiaan Wouters, Patrick J. van Gorp, Veerle Bieghs, Marion J. Gijbels, Hans Duimel, Dieter Lütjohann, Anja Kerksiek, Roger van Kruchten, Nobuyo Maeda, Bart Staels, Marc van Bilsen, Ronit Shiri-Sverdlov and Marten H. Hofker

      Version of Record online: 15 APR 2008 | DOI: 10.1002/hep.22363

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development (pages 487–496)

      Silke Marhenke, Jutta Lamlé, Laura Elisa Buitrago-Molina, José Manuel Fernández Cañón, Robert Geffers, Milton Finegold, Michael Sporn, Masayuki Yamamoto, Michael P. Manns, Markus Grompe and Arndt Vogel

      Version of Record online: 2 MAY 2008 | DOI: 10.1002/hep.22391

    2. You have free access to this content
      Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence (pages 497–507)

      Ying-Hong Shi, Wen-Xing Ding, Jian Zhou, Jun-Yi He, Yang Xu, Andrea A. Gambotto, Hannah Rabinowich, Jia Fan and Xiao-Ming Yin

      Version of Record online: 2 MAY 2008 | DOI: 10.1002/hep.22393

    3. You have free access to this content
      Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors (pages 508–518)

      Jun Yu, Qian Tao, Kin F. Cheung, Hongchuan Jin, Fan Fong Poon, Xian Wang, Hongyu Li, Yuen Y. Cheng, Christoph Röcken, Matthias P. A. Ebert, Anthony T. C. Chan and Joseph J. Y. Sung

      Version of Record online: 26 MAR 2008 | DOI: 10.1002/hep.22343

    4. You have free access to this content
      Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase (pages 519–530)

      Masanori Seimiya, Takeshi Tomonaga, Kazuyuki Matsushita, Masahiko Sunaga, Masamichi Oh-ishi, Yoshio Kodera, Tadakazu Maeda, Shigetsugu Takano, Akira Togawa, Hideyuki Yoshitomi, Masayuki Otsuka, Masakazu Yamamoto, Masayuki Nakano, Masaru Miyazaki and Fumio Nomura

      Version of Record online: 15 APR 2008 | DOI: 10.1002/hep.22364

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease (pages 531–540)

      Kanji Wakabayashi, Zhe-Xiong Lian, Patrick S.C. Leung, Yuki Moritoki, Koichi Tsuneyama, Mark J. Kurth, Kit S. Lam, Katsunori Yoshida, Guo-Xiang Yang, Toshifumi Hibi, Aftab A. Ansari, William M. Ridgway, Ross L. Coppel, Ian R. Mackay and M. Eric Gershwin

      Version of Record online: 2 MAY 2008 | DOI: 10.1002/hep.22390

    2. You have free access to this content
      Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology (pages 541–549)

      Julia L. Newton, Kieren G. Hollingsworth, Roy Taylor, Ahmed M. El-Sharkawy, Zia Uda Khan, Ruth Pearce, Kathryn Sutcliffe, Oke Okonkwo, Adrian Davidson, Jennifer Burt, Andrew M. Blamire and David Jones

      Version of Record online: 16 APR 2008 | DOI: 10.1002/hep.22371

    3. You have free access to this content
      Long-term follow-up of antimitochondrial antibody–positive autoimmune hepatitis (pages 550–556)

      Conor O'Brien, Supriya Joshi, Jordan J. Feld, Maha Guindi, Hans P. Dienes and E. Jenny Heathcote

      Version of Record online: 18 APR 2008 | DOI: 10.1002/hep.22380

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial (pages 557–566)

      Lindsay D. Plank, Edward J. Gane, Szelin Peng, Carl Muthu, Sachin Mathur, Lyn Gillanders, Kerry McIlroy, Anthony J. Donaghy and John L. McCall

      Version of Record online: 15 APR 2008 | DOI: 10.1002/hep.22367

    2. You have free access to this content
      Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo (pages 567–579)

      Boris Görg, Natalia Qvartskhava, Verena Keitel, Hans J. Bidmon, Oliver Selbach, Freimut Schliess and Dieter Häussinger

      Version of Record online: 28 MAR 2008 | DOI: 10.1002/hep.22345

    3. You have free access to this content
      Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding (pages 580–587)

      Gin-Ho Lo, Wen-Chi Chen, Chiun-Ku Lin, Wei-Lun Tsai, Hoi-Hung Chan, Tai-An Chen, Hsien-Chung Yu, Ping-I Hsu and Kwok-Hung Lai

      Version of Record online: 11 APR 2008 | DOI: 10.1002/hep.22358

  8. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury (pages 588–596)

      M. Isabel Lucena, Raúl J. Andrade, Carmen Martínez, Eugenia Ulzurrun, Elena García-Martín, Yolanda Borraz, M. Carmen Fernández, Manuel Romero-Gomez, Agustin Castiella, Ramón Planas, Joan Costa, Sandra Anzola and José A. G. Agúndez

      Version of Record online: 16 APR 2008 | DOI: 10.1002/hep.22370

    2. You have free access to this content
      Hepatic differentiation of human bone marrow–derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3β (pages 597–606)

      Kyoko Ishii, Yoko Yoshida, Yuji Akechi, Tomohiko Sakabe, Ren Nishio, Remina Ikeda, Kei Terabayashi, Yoshiaki Matsumi, Kazue Gonda, Hideharu Okamoto, Kazuko Takubo, Fumihito Tajima, Hiroyuki Tsuchiya, Yoshiko Hoshikawa, Akihiro Kurimasa, Akihiro Umezawa and Goshi Shiota

      Version of Record online: 15 APR 2008 | DOI: 10.1002/hep.22362

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice (pages 607–616)

      Fabian Geisler, Florian Nagl, Pawel K. Mazur, Marcel Lee, Ursula Zimber-Strobl, Lothar J. Strobl, Freddy Radtke, Roland M. Schmid and Jens T. Siveke

      Version of Record online: 18 APR 2008 | DOI: 10.1002/hep.22381

    2. You have free access to this content
      Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus (pages 617–623)

      Giacomo Manenti, Antonella Galvan, F. Stefania Falvella, Rosa M. Pascale, Elena Spada, Silvano Milani, Anna Gonzalez Neira, Francesco Feo and Tommaso A. Dragani

      Version of Record online: 16 APR 2008 | DOI: 10.1002/hep.22374

    3. You have free access to this content
      Multidrug resistance–associated proteins are crucial for the viability of activated rat hepatic stellate cells (pages 624–634)

      Rebekka A. Hannivoort, Sandra Dunning, Sara Vander Borght, Ben Schroyen, Jannes Woudenberg, Fiona Oakley, Manon Buist-Homan, Fiona A. J. van den Heuvel, Mariska Geuken, Albert Geerts, Tania Roskams, Klaas Nico Faber and Han Moshage

      Version of Record online: 28 MAR 2008 | DOI: 10.1002/hep.22346

    4. You have free access to this content
      Genetic polymorphism of hepatocyte nuclear factor-4α influences human cytochrome P450 2D6 activity (pages 635–645)

      Sang Seop Lee, Eun-Young Cha, Hyun-Ju Jung, Ji-Hong Shon, Eun-Young Kim, Chang-Woo Yeo and Jae-Gook Shin

      Version of Record online: 2 MAY 2008 | DOI: 10.1002/hep.22396

    5. You have free access to this content
      Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration (pages 646–654)

      Ahmed Zaid, Anna Roubtsova, Rachid Essalmani, Jadwiga Marcinkiewicz, Ann Chamberland, Josée Hamelin, Michel Tremblay, Hélène Jacques, Weijun Jin, Jean Davignon, Nabil G. Seidah and Annik Prat

      Version of Record online: 11 APR 2008 | DOI: 10.1002/hep.22354

  10. Meeting Report

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Future trends in hepatology: Challenges and opportunities (pages 655–661)

      Vinod K. Rustgi, Gary L. Davis, Steven K. Herrine, Arthur J. McCullough, Scott L. Friedman and Gregory J. Gores

      Version of Record online: 9 JUN 2008 | DOI: 10.1002/hep.22451

  11. Reviews

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Statins in liver disease: A molehill, an iceberg, or neither? (pages 662–669)

      Curtis K. Argo, Paola Loria, Stephen H. Caldwell and Amedeo Lonardo

      Version of Record online: 9 MAY 2008 | DOI: 10.1002/hep.22402

    2. You have free access to this content
      Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis (pages 670–678)

      Jacquelyn J. Maher, Pablo Leon and James C. Ryan

      Version of Record online: 2 MAY 2008 | DOI: 10.1002/hep.22399

  12. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Metagenomics and the case of the deadly hamster (pages 679–683)

      Andrew L. Mason, Karen Doucette and Gane Ka-Shu Wong

      Version of Record online: 9 JUN 2008 | DOI: 10.1002/hep.22452

    2. You have free access to this content
      A yellow bullet against the drivers of hepatic fibrogenesis (pages 683–685)

      Ralf Weiskirchen and Frank Lammert

      Version of Record online: 9 JUN 2008 | DOI: 10.1002/hep.22457

  13. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome (page 686)

      Georgios N. Kalambokis and Epameinondas V. Tsianos

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22247

    2. You have free access to this content
      Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy? (pages 686–687)

      Rafael Bañares, Agustín Albillos and María-Vega Catalina

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22328

    3. You have free access to this content
      Reply: (page 687)

      Peter Ferenci and Ludwig Kramer

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22406

    4. You have free access to this content
      Serum aminotransferase activity and mortality risk (pages 687–688)

      Daniele Prati, Agostino Colli and Laura Porretti

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22361

    5. You have free access to this content
      Reply: (page 688)

      W. Ray Kim and Terry M. Therneau

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22408

    6. You have free access to this content
    7. You have free access to this content
      Reply: (pages 689–690)

      Robert J. Fontana

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22415

    8. You have free access to this content
    9. You have free access to this content
      Reply: (pages 690–691)

      Joanne B. Krasnoff, Nathan M. Bass, Patricia L. Painter and Raphael B. Merriman

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22410

    10. You have free access to this content
      Children with chronic hepatitis C: What future? (pages 691–692)

      Raffaele Iorio, Francesco Cirillo, Vito Terlizzi and Antonietta Giannattasio

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22389

    11. You have free access to this content
      Reply: (page 692)

      Zachary D. Goodman, Hala R. Makhlouf, Lea Liu, William Balistreri, Regino P. Gonzalez-Peralta, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith and Kathleen B. Schwarz

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22405

    12. You have free access to this content
      Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure (pages 692–693)

      Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Yen Hsieh and Ming-Lung Yu

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22409

    13. You have free access to this content
      Reply: (pages 693–694)

      Véronique Loustaud-Ratti, Sophie Alain, Annick Rousseau and Pierre Marquet

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22454

    14. You have free access to this content
      Short treatment to patients with genotype 2 or 3 (page 694)

      Olav Dalgard and Alessandra Mangia

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22416

    15. You have free access to this content
      Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection (page 695)

      Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Amar P. Dhillon, Åsa Alsiö, Kristoffer Hellstrand, Johan Westin, Peer Christensen, Peter Leutscher and Gunnar Norkrans

      Version of Record online: 29 JUL 2008 | DOI: 10.1002/hep.22450

  14. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Correspondence
    15. Viral Hepatitis
    1. You have free access to this content
      Retracted: Outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen

      Chee-Kin Hui, Winnie W. Cheung, Kar-Wai Leung, Vincent C. C. Cheng, Bone S. F. Tang, Iris W. S. Li, John M. Luk, Nikki P. Lee, Yok-Lam Kwong, Wing-Yan Au, Kwok-Yung Yuen, George K. Lau and Raymond Liang

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/hep.22213

SEARCH

SEARCH BY CITATION